Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021
06 Jan 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses the cholesterol-lowering market, and recent results for the company's lead drug candidate, which achieved a 57% reduction in total cholesterol.